![Matthew Lumley](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Matthew Lumley
Directeur Général chez Myosana Therapeutics, Inc.
Profil
Matthew Lumley is currently the Chief Executive Officer at Myosana Therapeutics, Inc. and a Venture Partner at Medicxi Ventures (Jersey) Ltd.
He completed his undergraduate degree at Imperial College London in 2007 and his doctorate degree at King's College London in 2015.
Postes actifs de Matthew Lumley
Sociétés | Poste | Début |
---|---|---|
Medicxi Ventures (Jersey) Ltd.
![]() Medicxi Ventures (Jersey) Ltd. Investment ManagersFinance Medicxi Ventures (Jersey) Ltd. (Medicxi) is an independent venture capital firm founded in 2016 by Francesco de Rubertis, Michèle Ollier, and Kevin S. Johnson. The firm is headquartered in London. | Private Equity Investor | 01/01/2023 |
Myosana Therapeutics, Inc.
![]() Myosana Therapeutics, Inc. BiotechnologyHealth Technology Myosana Therapeutics, Inc. is a biotech company develops novel platform technology. The company was founded by Stan Froehner, Nick Whitehead and Steve Runnels and is headquartered in Seattle, WA. | Directeur Général | 01/11/2021 |
Formation de Matthew Lumley
Imperial College London | Undergraduate Degree |
King's College London | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 2 |
---|---|
Medicxi Ventures (Jersey) Ltd.
![]() Medicxi Ventures (Jersey) Ltd. Investment ManagersFinance Medicxi Ventures (Jersey) Ltd. (Medicxi) is an independent venture capital firm founded in 2016 by Francesco de Rubertis, Michèle Ollier, and Kevin S. Johnson. The firm is headquartered in London. | Finance |
Myosana Therapeutics, Inc.
![]() Myosana Therapeutics, Inc. BiotechnologyHealth Technology Myosana Therapeutics, Inc. is a biotech company develops novel platform technology. The company was founded by Stan Froehner, Nick Whitehead and Steve Runnels and is headquartered in Seattle, WA. | Health Technology |